Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.

One hundred and thirty-nine untreated patients with acute myelogenous leukaemia (AML) were admitted between August 1970 and December 1973 and allocated into two remission treatment regimens: one to receive chemotherapy alone and the other chemotherapy with immunotherapy. Of the patients who attained...

Descripción completa

Detalles Bibliográficos
Autores principales: Powles, R. L., Russell, J., Lister, T. A., Oliver, T., Whitehouse, J. M., Malpas, J., Chapuis, B., Crowther, D., Alexander, P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1977
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025283/
https://www.ncbi.nlm.nih.gov/pubmed/322689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025283/
https://www.ncbi.nlm.nih.gov/pubmed/322689

Ejemplares similares